A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanes

A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanes

BACKGROUND AND OBJECTIVES: Many patients with relapsed metastatic breast cancer are pre-treated with taxanes and anthracyclines, which are usually given in the neoadjuvant/adjuvant setting or as first-line treatment for metastatic disease. The primary objective of this study was to determine the ove...

Full description

Bibliographic Details
Main Authors: Hanna Kohail, Samir Shehata, Omar Mansour, Youssri Gouda, Rabbab Gaafar, Thoraya Abdel Hamid, Saiid El Nowieam, Ahmed Al Khodary, Heba El Zawahry, Ahmed Abdel Wareth, Iman Abdel Halim, Fouad Abou Taleb, Emad Hamada, Mohsen Barsoum, Mohamed Abdullah, Mohamed Meshref
Format: Article
Language:English
Published: Elsevier 2012-01-01
Series:Hematology/Oncology and Stem Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S165838761250004X

Internet

http://www.sciencedirect.com/science/article/pii/S165838761250004X

Similar Items